Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) updated its FY16 earnings guidance on Monday. The company provided earnings per share guidance of $ 9.90-10.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $ 10.02. The company issued revenue guidance of $ 1.485-1.53 billion, compared to the consensus revenue estimate of $ 1.49 billion. A number of […]
Sports Perspectives
Monday, January 9, 2017
Jazz Pharmaceuticals PLC (JAZZ) Updates FY16 Earnings Guidance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment